Literature DB >> 21898494

Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?

José M Mato1, Shelly C Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21898494     DOI： 10.1002/hep.24642

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

2.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.

Authors:  J Barr; J Caballería; I Martínez-Arranz; A Domínguez-Díez; C Alonso; J Muntané; M Pérez-Cormenzana; C García-Monzón; R Mayo; A Martín-Duce; M Romero-Gómez; O Lo Iacono; J Tordjman; R J Andrade; M Pérez-Carreras; Y Le Marchand-Brustel; A Tran; C Fernández-Escalante; E Arévalo; M García-Unzueta; K Clement; J Crespo; P Gual; M Gómez-Fleitas; M L Martínez-Chantar; A Castro; S C Lu; M Vázquez-Chantada; J M Mato
Journal:  J Proteome Res       Date:  2012-03-15       Impact factor: 4.466

3.  Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Authors:  Mazen Noureddin; Jessica Lam; Michael R Peterson; Michael Middleton; Gavin Hamilton; Thuy-Anh Le; Ricki Bettencourt; Chris Changchien; David A Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

4.  Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?

Authors:  Ahilan Arulanandan; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2015-04-22

5.  The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis.

Authors:  Joeri Lambrecht; Stefaan Verhulst; Hendrik Reynaert; Leo A van Grunsven
Journal:  Cells       Date:  2019-08-29       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.